EMD formulation comprising PGA
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 17, 2017
Issued Date -
Aug 15, 2013
app pub date -
Oct 17, 2011
filing date -
Oct 15, 2010
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Enamel Matrix Derivative (EMD) proteins and enamel matrix proteins are widely used in clinical dentistry because of their ability to promote regeneration of soft and hard tissues and to reduce inflammation and infections. The present invention relates to the surprising finding that a pharmaceutical, dental and/or cosmetic formulation, which comprises purified Enamel Matrix Derivative (EMD) proteins and/or enamel matrix proteins and sterilized Propylene Glycol Alginate (PGA), wherein the sterilized PGA is obtained from non-sterilized PGA having a weight average molecular weight (Mwo) of between 250-500 kDa, is more stable over time, especially, the pH is more stable over time.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2011 Application Filing Year
- A61K Class
- 10915 Applications Filed
- 8360 Patents Issued To-Date
- 76.60 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 8 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Apr 17, 2025 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Apr 17, 2029 |
